dodd-healthrelated-2006.pdf (3.41 MB)
Health-related quality of life and functioning in bipolar disorder : the impact of pharmacotherapy
journal contribution
posted on 2006-10-01, 00:00 authored by Michael BerkMichael Berk, Karen Hallam, N Lucas, L Kader, C MacNeil, Melissa Hasty, Seetal DoddSeetal Dodd, G Malhi, P ConusBipolar disorder has a major deleterious impact on many aspects of a patient's functioning and health-related quality of life. Although the formal measurement of these deficits has been neglected until recently, many well-designed trials now include an assessment of functioning and health-related quality of life using one or more rating scales. This review describes recent developments in the measurement of functioning and health-related quality of life in bipolar disorder, and discusses the evidence that medications that improve symptoms in bipolar disorder also offer clinically relevant benefits in functioning and health-related quality of life. Direct comparisons of the benefits of medications including atypical antipsychotics are problematic due to differences in trial populations, study durations and rating scales. Data from quetiapine trials indicate that this medication offers prompt and sustained improvement of functioning in patients with mania and enhancement of health-related quality of life in patients with bipolar depression, to accompany the significant improvements in mood episodes.
History
Journal
Expert review of pharmacoeconomics and outcomes researchVolume
6Issue
5Pagination
509 - 523Publisher
Expert ReviewsLocation
London, EnglandISSN
1473-7167eISSN
1744-8379Language
engNotes
Reproduced with the kind permission of the copyright owner.Publication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2006, Expert ReviewsUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC